Sitacure-M 50/500 contains two active ingredients, Sitagliptin 50mg and Metformin Hydrochloride 500mg, which work through complementary mechanisms to support blood glucose control in adults with type 2 diabetes. Sitagliptin is a DPP-4 inhibitor that helps regulate incretin-related pathways, supporting glucose-dependent insulin release and reducing glucagon secretion when blood glucose levels are elevated. Metformin, a biguanide, primarily reduces glucose production by the liver and also improves the body's response to insulin.

By combining these two mechanisms, Sitacure-M 50/500 may help improve glycaemic control when appropriately prescribed as part of an overall diabetes management plan. The medicine is intended to be used alongside suitable dietary habits, physical activity and regular medical monitoring. Patients should take it according to their healthcare professional's instructions and should not change the prescribed dose or stop treatment without medical advice.

Read more : https://hertzpharma.com/sitacure-m-50-500.php